SIGA Announces Start of TPOXX® Post-Exposure Prophylactic ("PEP") Clinical Trials - Stockhouse
3/2/2022 12:00:00 AM4 yearsago
by Stockhouse.com
by Stockhouse.com
SIGA Announces Start of TPOXX® Post-Exposure Prophylactic ("PEP") Clinical Trials
NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it ha… [+6203 chars]
full article...